BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33840154)

  • 1. Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study.
    Rögnvaldsson S; Aspelund T; Thorsteinsdóttir S; Turesson I; Björkholm M; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Jul; 107(1):137-144. PubMed ID: 33840154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.
    Kristinsson SY; Tang M; Pfeiffer RM; Björkholm M; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
    Blood; 2010 Oct; 116(15):2651-5. PubMed ID: 20610813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture risk in monoclonal gammopathy of undetermined significance.
    Melton LJ; Rajkumar SV; Khosla S; Achenbach SJ; Oberg AL; Kyle RA
    J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
    Lindqvist EK; Landgren O; Lund SH; Turesson I; Hultcrantz M; Goldin L; Björkholm M; Kristinsson SY
    Ann Hematol; 2017 Feb; 96(2):261-269. PubMed ID: 27807648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the significance of monoclonal gammopathy of undetermined significance?
    Atkin C; Richter A; Sapey E
    Clin Med (Lond); 2018 Oct; 18(5):391-396. PubMed ID: 30287433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis.
    Veronese N; Luchini C; Solmi M; Sergi G; Manzato E; Stubbs B
    J Bone Miner Metab; 2018 Jan; 36(1):128-132. PubMed ID: 28243796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
    Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
    Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
    Kleinstern G; Larson DR; Allmer C; Norman AD; Muntifering G; Sinnwell J; Visram A; Rajkumar V; Dispenzieri A; Kyle RA; Slager SL; Kumar S; Vachon CM
    Blood Cancer J; 2022 Apr; 12(4):67. PubMed ID: 35440099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
    Eythorsson E; Rognvaldsson S; Thorsteinsdottir S; Einarsson Long T; Reed ER; Sigurdardottir GA; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Olafsson I; Thorsteinsdottir I; Sveinsdottir SV; Sigurdsson F; Thordardottir AR; Palsson R; Indridason OS; Jonsson A; Gislason GK; Olafsson A; Sigurdsson J; Steingrimsdottir H; Hultcrantz M; Durie BGM; Harding S; Landgren O; Aspelund T; Love TJ; Kristinsson SY
    Ann Intern Med; 2024 Apr; 177(4):449-457. PubMed ID: 38560901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
    Baldursdóttir TR; Löve ÞJ; Gíslason GK; Björkholm M; Mellqvist UH; Lund SH; Blimark CH; Turesson I; Hultcrantz M; Landgren O; Kristinsson SY
    Eur J Haematol; 2021 Mar; 106(3):380-388. PubMed ID: 33295006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
    Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance.
    Farr JN; Zhang W; Kumar SK; Jacques RM; Ng AC; McCready LK; Rajkumar SV; Drake MT
    Blood; 2014 Jan; 123(5):647-9. PubMed ID: 24227822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
    Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
    Cohen AL; Sarid R
    Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance.
    Sandecká V; Hájek R; Pour L; Špička I; Ščudla V; Gregora E; Radocha J; Walterová L; Kessler P; Zahradová L; Adamová D; Valentova K; Vonke I; Obernauerová J; Starostka D; Wróbel M; Brožová L; Jarkovský J; Mikulášová A; Říhová L; Ševčíková S; Straub J; Minařík J; Adam Z; Krejčí M; Král Z; Maisnar V;
    Eur J Haematol; 2017 Jul; 99(1):80-90. PubMed ID: 28384387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.